Shenyang Yamanouchi Completes New Factory

29 May 1997

Shenyang Yamanouchi Pharmaceutical, a joint venture company formed bythe Japanese pharmaceutical firm Yamanouchi and the Shenyang No 1 Pharmaceutical Manufacturing Factory, has completed construction of a new factory in the Shenyang economic and technological development zone in China.

The 70,000-square meter site houses a three-storey ferroconcrete building with state-of-the-art facilities capable of producing up to 30 million solid formulation oral tablets per month. The building also includes a logistics center with storage capacity of around 1,200 square meters and an office and welfare facility of some 1,800 square meters.

Construction costs were around 2.2 billion yen ($19 million) and was initiated in March 1995.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight